Tempus AI, Inc. (NASDAQ: TEM) today announced results from a study evaluating an AI-enabled pre-screening panel for patients with advanced non-small cell lung cancer (NSCLC). The panel achieved ...
A prospective study in North Macedonia found that pharmacist-interpreted multiplex PCR testing enabled antibiotic ...
HELEN-Trio 011 shows camrelizumab plus anthracycline-free docetaxel-carboplatin improves pCR in stage II–III TNBC with ...
Penicillin has cured syphilis cases since 1943, but symptoms of the sexually transmitted infection, known as "the great ...
Elizabeth Holmes founded Theranos in 2003 at the age of 19 and promised to revolutionize blood testing — before it all came ...
Same-day test helps detect hidden infections in critically ill children A pioneering same-day test has been used to detect ...
Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform ...
In 2025, Visby launched an FDA-authorized at-home STI test for women that can detect chlamydia, gonorrhea, and trichomoniasis in 30 minutes—no need to mail in samples for testing—with clinical ...
Biological age tests claim to inform you about how your body is faring by telling you what age your blood test results most ...
Global Cell and Gene Therapy Bioanalytical Testing Services Market was valued at USD 612.50 Million in 2025 and is expected to grow to USD 1,347.03 Million by 2035, registering a CAGR of 8.20% from ...
Background Tumour testing for microsatellite instability (MSI) or mismatch repair deficiency (dMMR) is used to screen for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results